Literature DB >> 33457125

Guillain-Barré Syndrome During the Postpartum Period.

Mohammed Aabdi1, Yassine Mellagui1, Amine Bensaid1, Houssam Bkiyar1, Brahim Housni1.   

Abstract

Guillain-Barré syndrome (GBS) is an acute peripheral neuropathy that manifests with ascending symmetrical and progressive weakness or paralysis with the absence of reflexes. The incidence of this syndrome in pregnancy and postpartum periods is similar to the general population; however, few published clinical cases have been described. Here, we report the case of a 26-year-old patient who developed GBS with respiratory distress two weeks after her baby's delivery that required long-term mechanical ventilation. The patient's clinical conditions were significantly improved after the use of immunoglobulins and rehabilitation, and she was discharged. Physicians should be aware of the possibility of developing GBS during pregnancy and postpartum periods.
Copyright © 2020, Aabdi et al.

Entities:  

Keywords:  case report; guillain-barré syndrome; postpartum

Year:  2020        PMID: 33457125      PMCID: PMC7797439          DOI: 10.7759/cureus.12021

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  20 in total

Review 1.  Management of children with Guillain-Barré syndrome.

Authors:  S Agrawal; D Peake; W P Whitehouse
Journal:  Arch Dis Child Educ Pract Ed       Date:  2007-12       Impact factor: 1.309

2.  Cytoalbuminologic dissociation in Asian patients with Guillain-Barré and Miller Fisher syndromes.

Authors:  Anna Hiu Yi Wong; Thirugnanam Umapathi; Yukihiro Nishimoto; Yu Zhong Wang; Yee Cheun Chan; Nobuhiro Yuki
Journal:  J Peripher Nerv Syst       Date:  2015-03       Impact factor: 3.494

3.  Guillain-Barré syndrome: MR imaging findings of the spine in eight patients.

Authors:  W M Byun; W K Park; B H Park; S H Ahn; M S Hwang; J C Chang
Journal:  Radiology       Date:  1998-07       Impact factor: 11.105

Review 4.  Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis.

Authors:  James J Sejvar; Andrew L Baughman; Matthew Wise; Oliver W Morgan
Journal:  Neuroepidemiology       Date:  2011-03-21       Impact factor: 3.282

5.  Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barré syndrome: a randomized trial.

Authors:  Rudolf Korinthenberg; Joachim Schessl; Janbernd Kirschner; Jürgen Schulte Mönting
Journal:  Pediatrics       Date:  2005-07       Impact factor: 7.124

Review 6.  Animal models of autoimmune neuropathy.

Authors:  Betty Soliven
Journal:  ILAR J       Date:  2014

Review 7.  Guillain-Barré syndrome in pregnancy.

Authors:  Louis Yik-Si Chan; Michelle Hang-Yuet Tsui; Tse Ngong Leung
Journal:  Acta Obstet Gynecol Scand       Date:  2004-04       Impact factor: 3.636

8.  Hyperacute onset of Guillain Barre Syndrome in the immediate postpartum period following Caesarean section under spinal anaesthesia.

Authors:  Byrappa Vinay; Bansal Sonia; Varadarajan Bhadrinarayan
Journal:  Indian J Anaesth       Date:  2015-06

9.  Guillain-Barre Syndrome in Postpartum Period: Rehabilitation Issues and Outcome - Three Case Reports.

Authors:  Anupam Gupta; Maitreyi Patil; Meeka Khanna; Rashmi Krishnan; Arun B Taly
Journal:  J Neurosci Rural Pract       Date:  2017 Jul-Sep

10.  Relapsing Guillain-Barre syndrome in pregnancy and postpartum.

Authors:  S Meenakshi-Sundaram; K Swaminathan; S N Karthik; S Bharathi
Journal:  Ann Indian Acad Neurol       Date:  2014-07       Impact factor: 1.383

View more
  2 in total

1.  Guillain Barre syndrome as a complication of SARS-CoV-2 infection: A case report.

Authors:  Ghizlane El Aidouni; Salma Touihar; Manal Merbouh; Mohammed Aabdi; Abderrahim El Kaouini; Amine Bouabdallaoui; Ounci Es-Saad; Houssam Bkiyar; Brahim Housni
Journal:  Ann Med Surg (Lond)       Date:  2021-08-05

2.  Guillan barre syndrome in post Covid-19 infection in children.

Authors:  Sanae El Mezzeoui; Fatima Zahra Aftiss; Mohammed Aabdi; Houssam Bkiyar; Brahim Housni
Journal:  Ann Med Surg (Lond)       Date:  2021-06-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.